The older archives (>10 years old) have been substantially recovered -- more than 23,800 files' worth -- and are now reachable through the search engine and via file download. Email here if you have any questions.
Your support is essential if the service is to continue, there are bandwidth bills to pay every month and failing disk drives to replace. Volunteers do the work, but disk drives and bandwidth are not free. We encourage you to contribute financially, even a dollar helps. Click here to donate.
Welcome to the new Radio4all website! If you cannot log in, you may need to reset your password. Email here if you need additional support.
 
Program Information
Politics and Science
Social Engineering and Crimes Against Humanity
Weekly Program
Anna Brees, Dr. Michael Yeadon, Emma Kenny
 Politics and Science  Contact Contributor
Nov. 5, 2020, 6:59 p.m.
The interview of Michael Yeadon is done by ex BBC Presenter Anna Brees, and her website is https://www.breesmedia.co.uk , she also has a youtube channel.
Emma Kenny is a TV Psychologist & Presenter and can be found at https://www.ekenny.co.uk
Thanks to Anna Breess, Dr. Michael Yeadon, and Emma Kenny for allowing me to share their material.
Dr. Yeadon is an Allergy & Respiratory Therapeutic Area expert, developed out of deep knowledge of biology & therapeutics and is an innovative drug discoverer with 23y in the pharmaceutical industry. He trained as a biochemist and pharmacologist, obtaining his PhD from the University of Surrey (UK) in 1988 on the CNS and peripheral pharmacology of opioids on respiration. Dr Yeadon then worked at the Wellcome Research Labs with Salvador Moncada with a research focus on airway hyper-responsiveness and effects of pollutants including ozone and working in drug discovery of 5-LO, COX, PAF, NO and lung inflammation. With colleagues, he was the first to detect exhaled NO in animals and later to induce NOS in lung via allergic triggers. Joining Pfizer in 1995, he was responsible for the growth and portfolio delivery of the Allergy & Respiratory pipeline within the company. During his tenure at Pfizer, Dr Yeadon was responsible for target selection and the progress into humans of new molecules, leading teams of up to 200 staff across all disciplines and won an Achievement Award for productivity in 2008. Under his leadership the research unit invented oral and inhaled NCEs which delivered multiple positive clinical proofs of concept in asthma, allergic rhinitis and COPD. He led productive collaborations such as with Rigel Pharmaceuticals (SYK inhibitors) and was involved in the licensing of Spiriva® and acquisition of the Meridica (inhaler device) company. Dr Yeadon has published over 40 original research articles and now consults and partners with a number of biotechnology companies. Before working with Apellis, Dr Yeadon was VP and Chief Scientific Officer (Allergy & Respiratory Research) with Pfizer.

Download Program Podcast
00:59:28 1 Oct. 30, 2020
  View Script
    
 00:59:28  80Kbps mp3
(35MB) Stereo
683 Download File...